---
title: "SINOTHERAPEUTICS: Net profit of 45.5857 million yuan in the first half of 2025, a year-on-year decrease of 15.82%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/254117010.md"
description: "SINOTHERAPEUTICS announced that in the first half of 2025, the operating income was 220 million yuan, a year-on-year increase of 0.74%. The net profit was 45.5857 million yuan, a year-on-year decrease of 15.82%. The company plans to distribute a cash dividend of 0.25 yuan for every 10 shares to all shareholders, with a total cash dividend distribution of 11.2251 million yuan, accounting for 24.62% of the net profit attributable to the parent company's shareholders for the period from January to June 2025"
datetime: "2025-08-22T07:59:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/254117010.md)
  - [en](https://longbridge.com/en/news/254117010.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/254117010.md)
generator: "portal-rs"
---

# SINOTHERAPEUTICS: Net profit of 45.5857 million yuan in the first half of 2025, a year-on-year decrease of 15.82%

SINOTHERAPEUTICS announced that its operating revenue in the first half of 2025 was 220 million yuan, a year-on-year increase of 0.74%. The net profit was 45.5857 million yuan, a year-on-year decrease of 15.82%. The company plans to distribute a cash dividend of 0.25 yuan for every 10 shares to all shareholders, with a total cash dividend of 11.2251 million yuan, accounting for 24.62% of the net profit attributable to the parent company's shareholders for the period from January to June 2025

### Related Stocks

- [688247.CN](https://longbridge.com/en/quote/688247.CN.md)

## Related News & Research

- [HENGRUI PHARMA  1H26 Net Profit Rises 0.3% YoY to RMB4.465 Billion; Shares Now Down Over 7%](https://longbridge.com/en/news/296422700.md)
- [Oura exploring how its ring could detect brain hemorrhages after Bill Ackman suggests it could have helped his daughter](https://longbridge.com/en/news/296658401.md)
- [APT Medical: H1 2026 revenue and profit rose over 25% year-over-year, with strong growth in core segments](https://longbridge.com/en/news/296363764.md)
- [Innova Captab Revises FY26 Accounts and Clears Baddi Plant Expansion](https://longbridge.com/en/news/296661728.md)
- [Innventure directors force management, board to forfeit Accelsius earnout shares tied to DarkNX order](https://longbridge.com/en/news/296352522.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**